Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie’s Disease, Subgrouped by Penile Plaque Calcification.

To examine the long-term (5-year) efficacy and safety of collagenase clostridium histolyticum (CCH) therapy in men with Peyronie’s disease (PD) and varying degrees of plaque calcification.

CCH-treated adult men from the 12-month IMPRESS I/II or 9-month open-label studies were eligible.